drugset / Trial / NCT04716413

Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment

NCT04716413

Phase 4 Terminated 3 enrolled Montefiore Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.

Timeline

Start
2021-09-27
Primary completion
2022-11-17
Completion
2022-11-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified 30 ug Other

Indications

No indication recorded.